Search research articles
Contact Us
Filters
Showing results (21-30 of 50) with videos related to
Page
of 5
Sort By:
Health Technology Assessment (Winchester, England)
|
November 21, 2007
Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial
L Sharples, V Hughes, A Crean, et al.
Therapeutic Drug Monitoring
|
March 2, 1999
Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients
A Trull, L Steel, L Sharples, et al.
Health Technology Assessment (Winchester, England)
|
December 1, 2006
Evaluation of the ventricular assist device programme in the UK
L Sharples, M Buxton, N Caine, et al.
Thorax
|
April 19, 2000
Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer
C Laroche, I Fairbairn, H Moss, et al.
The American Journal of Cardiology
|
March 29, 2001
Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization
S M Burns, S Brown, C A White, et al.
International Journal of Cardiology
|
March 17, 1999
HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy
A A Harcombe, L Sharples, S R Large, et al.
Thorax
|
March 3, 2005
Effect of lung cancer surgery on quality of life
T Win, L Sharples, F C Wells, et al.
Cancer
|
April 1, 1990
The epidermal growth factor receptor and the prognosis of bladder cancer
D E Neal, L Sharples, K Smith, et al.
International Journal of Cardiology
|
April 23, 1999
Balloon mitral valvuloplasty: comparison of haemodynamic and echocardiographic assessment of mitral stenosis at different heart rates in the catheterisation laboratory
A A Harcombe, P F Ludman, C Wisbey, et al.
Health Technology Assessment (Winchester, England)
|
August 15, 2006
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context
M Buxton, N Caine, D Chase, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 50) with videos related to
Sort By:
Page
of 5
Health Technology Assessment (Winchester, England)
|
November 21, 2007
Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial
L Sharples, V Hughes, A Crean, et al.
Therapeutic Drug Monitoring
|
March 2, 1999
Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients
A Trull, L Steel, L Sharples, et al.
Health Technology Assessment (Winchester, England)
|
December 1, 2006
Evaluation of the ventricular assist device programme in the UK
L Sharples, M Buxton, N Caine, et al.
Thorax
|
April 19, 2000
Role of computed tomographic scanning of the thorax prior to bronchoscopy in the investigation of suspected lung cancer
C Laroche, I Fairbairn, H Moss, et al.
The American Journal of Cardiology
|
March 29, 2001
Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization
S M Burns, S Brown, C A White, et al.
International Journal of Cardiology
|
March 17, 1999
HLA antigen frequencies in end-stage idiopathic and ischaemic cardiomyopathy
A A Harcombe, L Sharples, S R Large, et al.
Thorax
|
March 3, 2005
Effect of lung cancer surgery on quality of life
T Win, L Sharples, F C Wells, et al.
Cancer
|
April 1, 1990
The epidermal growth factor receptor and the prognosis of bladder cancer
D E Neal, L Sharples, K Smith, et al.
International Journal of Cardiology
|
April 23, 1999
Balloon mitral valvuloplasty: comparison of haemodynamic and echocardiographic assessment of mitral stenosis at different heart rates in the catheterisation laboratory
A A Harcombe, P F Ludman, C Wisbey, et al.
Health Technology Assessment (Winchester, England)
|
August 15, 2006
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context
M Buxton, N Caine, D Chase, et al.
Page
of 5